Norway
· Delayed Price · Currency is NOK Aker BioMarine AS Statistics
Total Valuation
Aker BioMarine AS has a market cap or net worth of NOK 9.12 billion. The enterprise value is 10.89 billion.
| Market Cap | 9.12B |
| Enterprise Value | 10.89B |
Important Dates
The next estimated earnings date is Friday, November 1, 2024.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Aker BioMarine AS has 87.69 million shares outstanding. The number of shares has increased by 5.42% in one year.
| Shares Outstanding | 87.69M |
| Shares Change (YoY) | +5.42% |
| Shares Change (QoQ) | +23.40% |
| Owned by Insiders (%) | 5.22% |
| Owned by Institutions (%) | 11.82% |
| Float | 11.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 52.52 |
| PS Ratio | 2.59 |
| PB Ratio | 2.65 |
| P/FCF Ratio | 29.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.83, with an EV/FCF ratio of 34.99.
| EV / Earnings | -5,108.25 |
| EV / Sales | 3.02 |
| EV / EBITDA | 17.83 |
| EV / EBIT | n/a |
| EV / FCF | 34.99 |
Financial Position
The company has a current ratio of 13.69, with a Debt / Equity ratio of 51.25.
| Current Ratio | 13.69 |
| Quick Ratio | 1.49 |
| Debt / Equity | 51.25 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 6.24 |
| Interest Coverage | 0.07 |
Financial Efficiency
Return on equity (ROE) is -3.11% and return on invested capital (ROIC) is 0.20%.
| Return on Equity (ROE) | -3.11% |
| Return on Assets (ROA) | 0.16% |
| Return on Capital (ROIC) | 0.20% |
| Revenue Per Employee | 9.67M |
| Profits Per Employee | -5,714 |
| Employee Count | 373 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +126.09% in the last 52 weeks. The beta is 0.86, so Aker BioMarine AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +126.09% |
| 50-Day Moving Average | 93.03 |
| 200-Day Moving Average | 66.32 |
| Relative Strength Index (RSI) | 64.51 |
| Average Volume (20 Days) | 100,726 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aker BioMarine AS had revenue of NOK 3.61 billion and -2.13 million in losses. Loss per share was -0.02.
| Revenue | 3.61B |
| Gross Profit | 1.15B |
| Operating Income | 22.38M |
| Pretax Income | -364.45M |
| Net Income | -2.13M |
| EBITDA | 591.43M |
| EBIT | 22.38M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 173.70 million in cash and 1.94 billion in debt, giving a net cash position of -1.77 billion or -20.16 per share.
| Cash & Cash Equivalents | 173.70M |
| Total Debt | 1.94B |
| Net Cash | -1.77B |
| Net Cash Per Share | -20.16 |
| Equity (Book Value) | 3.79B |
| Book Value Per Share | 39.19 |
| Working Capital | 5.56B |
Cash Flow
In the last 12 months, operating cash flow was 733.16 million and capital expenditures -421.99 million, giving a free cash flow of 311.17 million.
| Operating Cash Flow | 733.16M |
| Capital Expenditures | -421.99M |
| Free Cash Flow | 311.17M |
| FCF Per Share | 3.55 |
Margins
Gross margin is 31.89%, with operating and profit margins of 0.62% and -0.06%.
| Gross Margin | 31.89% |
| Operating Margin | 0.62% |
| Pretax Margin | -10.11% |
| Profit Margin | -0.06% |
| EBITDA Margin | 16.40% |
| EBIT Margin | 0.62% |
| FCF Margin | 8.63% |
Dividends & Yields
Aker BioMarine AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.42% |
| Shareholder Yield | -5.42% |
| Earnings Yield | -0.02% |
| FCF Yield | 3.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |